411 related articles for article (PubMed ID: 9749491)
1. Low rectal cancer: impact of radiation and chemotherapy on surgical treatment.
Habr-Gama A; de Souza PM; Ribeiro U; Nadalin W; Gansl R; Sousa AH; Campos FG; Gama-Rodrigues J
Dis Colon Rectum; 1998 Sep; 41(9):1087-96. PubMed ID: 9749491
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study.
Uzcudun AE; Batlle JF; Velasco JC; Sánchez Santos ME; Carpeño Jde C; Grande AG; Juberías AM; Piñeiro EH; Olivar LM; García AG
Dis Colon Rectum; 2002 Oct; 45(10):1349-58. PubMed ID: 12394434
[TBL] [Abstract][Full Text] [Related]
3. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.
Pucciarelli S; Toppan P; Friso ML; Russo V; Pasetto L; Urso E; Marino F; Ambrosi A; Lise M
Dis Colon Rectum; 2004 Nov; 47(11):1798-807. PubMed ID: 15622571
[TBL] [Abstract][Full Text] [Related]
4. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
[TBL] [Abstract][Full Text] [Related]
5. Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum.
Chari RS; Tyler DS; Anscher MS; Russell L; Clary BM; Hathorn J; Seigler HF
Ann Surg; 1995 Jun; 221(6):778-86; discussion 786-7. PubMed ID: 7794081
[TBL] [Abstract][Full Text] [Related]
6. Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer: preliminary results.
Tjandra JJ; Reading DM; McLachlan SA; Gunn IF; Green MD; McLaughlin SJ; Millar JL; Pedersen JS
Dis Colon Rectum; 2001 Aug; 44(8):1113-22. PubMed ID: 11535850
[TBL] [Abstract][Full Text] [Related]
7. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
8. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
Movsas B; Hanlon AL; Lanciano R; Scher RM; Weiner LM; Sigurdson ER; Hoffman JP; Eisenberg BL; Cooper HS; Provins S; Coia LR
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):43-50. PubMed ID: 9747818
[TBL] [Abstract][Full Text] [Related]
9. Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer.
Grann A; Minsky BD; Cohen AM; Saltz L; Guillem JG; Paty PB; Kelsen DP; Kemeny N; Ilson D; Bass-Loeb J
Dis Colon Rectum; 1997 May; 40(5):515-22. PubMed ID: 9152176
[TBL] [Abstract][Full Text] [Related]
10. Preoperative radiotherapy and concurrent chemotherapy with bolus 5-fluorouracil for rectal cancer: a prospective analysis of 98 patients.
Wygoda M; Rottenberg Y; Kadouri L; Pikarsky A; Hubert A
Tumori; 2010; 96(5):709-12. PubMed ID: 21302617
[TBL] [Abstract][Full Text] [Related]
11. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial.
Breugom AJ; van Gijn W; Muller EW; Berglund Å; van den Broek CBM; Fokstuen T; Gelderblom H; Kapiteijn E; Leer JWH; Marijnen CAM; Martijn H; Meershoek-Klein Kranenbarg E; Nagtegaal ID; Påhlman L; Punt CJA; Putter H; Roodvoets AGH; Rutten HJT; Steup WH; Glimelius B; van de Velde CJH
Ann Oncol; 2015 Apr; 26(4):696-701. PubMed ID: 25480874
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy with preoperative radiotherapy in rectal cancer.
Bosset JF; Collette L; Calais G; Mineur L; Maingon P; Radosevic-Jelic L; Daban A; Bardet E; Beny A; Ollier JC;
N Engl J Med; 2006 Sep; 355(11):1114-23. PubMed ID: 16971718
[TBL] [Abstract][Full Text] [Related]
14. Anal sphincter preservation in locally advanced low rectal adenocarcinoma after preoperative chemoradiation therapy and coloanal anastomosis.
Luna-Pérez P; Rodríguez-Ramírez S; Hernández-Pacheco F; Gutiérrez De La Barrera M; Fernández R; Labastida S
J Surg Oncol; 2003 Jan; 82(1):3-9. PubMed ID: 12501163
[TBL] [Abstract][Full Text] [Related]
15. Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3-T4 unresectable rectal cancer: a phase II IATTGI study.
Carraro S; Roca EL; Cartelli C; Rafailovici L; Castillo Odena S; Wasserman E; Gualdrini U; Huertas E; Barugel M; Ballarino G; Rodriguez MC; Masciangioli G
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):397-402. PubMed ID: 12243813
[TBL] [Abstract][Full Text] [Related]
16. Preoperative chemoradiotherapy and radical surgery for locally advanced distal rectal adenocarcinoma: pathologic findings and clinical implications.
Medich D; McGinty J; Parda D; Karlovits S; Davis C; Caushaj P; Lembersky B
Dis Colon Rectum; 2001 Aug; 44(8):1123-8. PubMed ID: 11535851
[TBL] [Abstract][Full Text] [Related]
17. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Breast and Bowel Project Protocol R-03.
Hyams DM; Mamounas EP; Petrelli N; Rockette H; Jones J; Wieand HS; Deutsch M; Wickerham L; Fisher B; Wolmark N
Dis Colon Rectum; 1997 Feb; 40(2):131-9. PubMed ID: 9075745
[TBL] [Abstract][Full Text] [Related]
18. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
Landry JC; Feng Y; Prabhu RS; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Benson AB
Oncologist; 2015 Jun; 20(6):615-6. PubMed ID: 25926352
[TBL] [Abstract][Full Text] [Related]
19. A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
Glynne-Jones R; Falk S; Maughan TS; Meadows HM; Sebag-Montefiore D
Br J Cancer; 2007 Feb; 96(4):551-8. PubMed ID: 17262086
[TBL] [Abstract][Full Text] [Related]
20. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
Chakravarthy A; Abrams RA; Yeo CJ; Korman LT; Donehower RC; Hruban RH; Zahurek ML; Grochow LB; O'Reilly S; Hurwitz H; Jaffee EM; Lillemoe KD; Cameron JL
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1089-96. PubMed ID: 11072167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
